DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.


Stay up to date

DRG's newsroom is a place where journalists and investors will find timely and relevant information related to Decision Resources Group and the healthcare industry. This section includes a current list of all press releases and announcements, and links to our thought leaders media mentions.

For media inquiries or to speak with an analyst, please contact:

DRG Media
  • Where is She Now? Reflections from UCB’s First Scholarship...
    September 17th, 2018
  • Teva Pharmaceuticals Europe: Patients Search for Information...
    September 14th, 2018
  • How Mylan Used Partnering Deals To Become A Key Player In...
    September 10th, 2018
  • Brain Wave: Breakthroughs Bring New Hope to CNS 
    September 07th, 2018
  • The hepatocellular carcinoma market
    August 31st, 2018
  • After rocky 2017, unicorn Clover Health charts path forward...
    August 30th, 2018
  • Brexit: The Good, The Bad, And The Chaos
    August 28th, 2018
  • Three drug-pricing controls emerge in U.S. market
    August 20th, 2018
  • 'Ask your doctor' pitches from digital ads work almost as...
    August 17th, 2018
  • DRG Names Chief Strategy Officer
    August 16th, 2018
  • Sensors to Smartphones Bring Patent Wars to Diabetes...
    August 13th, 2018
    August 09th, 2018
  • Pharma reps get more respect from doctors in Japan. What's...
    August 07th, 2018
  • Alzheimer's Cure Search Leads to a Crash, Raises More...
    August 06th, 2018
  • Addressing Out-Of-Pocket Specialty Drug Costs In Medicare...
    August 03rd, 2018
  • Vaccine scandal and heart drug recall show China’s pharma...
    August 02nd, 2018
  • Talend Helps Healthcare Analytics Company Integrate and...
    July 31st, 2018
  • Trastuzumab Biosimilar, Hervycta, Launches in India
    July 30th, 2018
  • Clinical development strategies for checkpoint inhibitors
    July 24th, 2018
  • New Affordable Care Act insurance choices for 2019 in...
    July 24th, 2018
  • A Cost-Utility Analysis Of Vertex's CF Drugs — What It...
    July 23rd, 2018
  • Liquidia Files for $50 Million IPO to Advance Drug Delivery...
    July 09th, 2018
  • Five things for pharma marketers to know: Monday, July 2,...
    July 04th, 2018
  • As Amazon enters market, patients, physicians hopeful for...
    July 02nd, 2018
49-72 of 181